IGMS IGM Biosciences Inc

Price (delayed)

$19.25

Market cap

$818.64M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.51

Enterprise value

$772.43M

Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing ...

Highlights
IGM Biosciences's debt has soared by 124% YoY and by 4% from the previous quarter
The company's net income has shrunk by 94% YoY and by 12% QoQ

Key stats

What are the main financial stats of IGMS
Market
Shares outstanding
42.53M
Market cap
$818.64M
Enterprise value
$772.43M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.06
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$185.41M
EBITDA
-$176.81M
Free cash flow
-$145.09M
Per share
EPS
-$5.51
Free cash flow per share
-$4.29
Book value per share
$6.29
Revenue per share
$0
TBVPS
$7.62
Balance sheet
Total assets
$257.74M
Total liabilities
$53.22M
Debt
$29.91M
Equity
$204.52M
Working capital
$170.44M
Liquidity
Debt to equity
0.15
Current ratio
7.23
Quick ratio
6.88
Net debt/EBITDA
0.26
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-59.9%
Return on equity
-70.1%
Return on invested capital
-119%
Return on capital employed
-80.5%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IGMS stock price

How has the IGM Biosciences stock price performed over time
Intraday
2.45%
1 week
26.31%
1 month
10.82%
1 year
-76.72%
YTD
-34.37%
QTD
-27.98%

Financial performance

How have IGM Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$185.57M
Net income
-$185.41M
Gross margin
N/A
Net margin
N/A
The company's net income has shrunk by 94% YoY and by 12% QoQ
The operating income has dropped by 92% year-on-year and by 12% since the previous quarter

Growth

What is IGM Biosciences's growth rate over time

Valuation

What is IGM Biosciences stock price valuation
P/E
N/A
P/B
3.06
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has dropped by 82% year-on-year and by 12% since the previous quarter
The stock's P/B is 48% below its last 4 quarters average of 5.9
IGM Biosciences's equity has decreased by 42% YoY and by 16% from the previous quarter

Efficiency

How efficient is IGM Biosciences business performance
The return on invested capital has dropped by 110% year-on-year
IGMS's return on equity has dropped by 108% year-on-year and by 28% since the previous quarter
The ROA has plunged by 93% YoY and by 24% from the previous quarter

Dividends

What is IGMS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IGMS.

Financial health

How did IGM Biosciences financials performed over time
IGMS's total liabilities has surged by 114% year-on-year
IGM Biosciences's quick ratio has shrunk by 69% YoY and by 17% QoQ
IGM Biosciences's debt is 85% less than its equity
IGM Biosciences's debt has soared by 124% YoY and by 4% from the previous quarter
IGM Biosciences's equity has decreased by 42% YoY and by 16% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.